A pre-Seed and Seed-stage venture capital firm is focused on AI and next-generation computing technologies applied to large industries. The firm prefers to invest in companies located in North America.
The firm partners with entrepreneurs addressing real-world problems through data and machine learning, with a focus on frontier technologies such as AI, computational biotech, connected sensors, AR/VR, and blockchain. Prior investment areas have included biomedical and genomics data analytics platforms, data and analysis tools for drug discovery, automated pathology solutions, and related technologies.
From a company and management team perspective, the firm seeks experienced teams with a strong long-term vision. The firm may take a board seat when the firm brings specific domain expertise relevant to the company. The firm does not have a fixed equity ownership target. The firm values strong technical teams with deep market understanding and is comfortable partnering with very early-stage companies, including those at the pre-product stage.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment